Date: 9.7.2018
Summary:
A German university has developed a marker for non-invasive diagnosis and differentiation of benign and malignant renal carcinoma. An unequivocal differentiation will improve the planning of the adequate treatment. The university offers a license agreement.
Reference: TODE20180309001
Country: Germany
Submitted: 9. 7. 2018
Keywords
Technology: Cytology, Cancerology, Oncology; Diagnostics, Diagnosis
Market: Differential diagnosis, Oncology
NACE: Other research and experimental development on natural sciences and engineering
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Enzyme biotechnology - Information about Enzyme biotechnology
Biotechnology Journals - Plant, environmetal, animal biotechnology journals
Reprogrammed T cells make mice (and maybe us) age slower
mRNA skin cancer therapy halves risk of death in clinical trial